MYND Life Sciences Inc. Aktie - Unternehmensdaten & Kurse - CA62857B1094 | goSPATZ

MYND Life Sciences Inc.

Share · CA62857B1094 (XCNQ)

No Price

n/a

Share Float & Liquidity

Free Float 100,00 %

Shares Float 47,82 M

Shares Outstanding 47,82 M

Company Profile for MYND Life Sciences Inc. Share

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company is headquartered in Kelowna, Canada.

Get up to date insights from finAgent about MYND Life Sciences Inc.

Company Data

Name MYND Life Sciences Inc.

Company MYND Life Sciences Inc.

Website https://www.myndsciences.com

Primary Exchange

CSE LISTED

ISIN CA62857B1094

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Wilfred A. Jefferies

Country Canada

Currency CAD

Employees -

Address 733 Finns Road, V1X 5B7 Kelowna

IPO Date 2021-05-27

Ticker Symbols

Name	Symbol
CSE LISTED	MYND.CN

More Shares

Investors who hold MYND Life Sciences Inc. also have the following shares in their portfolio:

EIB 20/32 MTN Bond

HELVETIA HOLDING AG Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025